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Introduction: Syncope is common among emergency department (ED) patients with acute pulmonary 
embolism (PE) and indicates a higher acuity and worse prognosis than in patients without syncope. 
Whether presyncope carries the same prognostic implications has not been established. We compared 
incidence of intensive care unit (ICU) admission in three groups of ED PE patients: those with presyncope; 
syncope; and neither. 
Methods: This retrospective cohort study included all adults with acute, objectively confirmed PE in 21 
community EDs from January 2013–April 2015. We combined electronic health record extraction with manual 
chart abstraction. We used chi-square test for univariate comparisons and performed multivariate analysis to 
evaluate associations between presyncope or syncope and ICU admission from the ED, reported as adjusted 
odds ratios (aOR) with 95% confidence intervals (CI).
Results: Among 2996 PE patients, 82 (2.7%) had presyncope and 109 (3.6%) had syncope. ICU admission 
was similar between groups (presyncope 18.3% vs syncope 25.7%) and different than their non-syncope 
counterparts (either 22.5% vs neither 4.7%; p<0.0001). On multivariate analysis, both presyncope and 
syncope were independently associated with ICU admission, controlling for demographics, higher-risk PE 
Severity Index (PESI) class, ventilatory support, proximal clot location, and submassive and massive PE 
classification: presyncope, aOR 2.79 (95% CI, 1.40, 5.56); syncope, aOR 4.44 (95% CI 2.52, 7.80). These 
associations were only minimally affected when excluding massive PE from the model. There was no 
significant interaction between either syncope or presyncope and PESI, submassive or massive classification 
in predicting ICU admission.
Conclusion: Presyncope appears to carry similar strength of association with ICU admission as syncope in 
ED patients with acute PE. If this is confirmed, clinicians evaluating patients with acute PE may benefit from 
including presyncope in their calculus of risk assessment and site-of-care decision-making. [West J Emerg 
Med. 2020;21(3)703-713.]
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Population Health Research Capsule
What do we already know about this issue?
Syncope in patients with acute pulmonary 
embolism (PE) indicates a worse prognosis than 
in those without syncope.
What was the research question?
Is presyncope associated with intensive care unit 
(ICU) admission in emergency department (ED) 
patients with acute PE?
What was the major finding of the study?
Presyncope, like syncope, is associated with ICU 
admission in ED patients with PE, even when 
adjusted for high-risk variables. 
How does this improve population health?
Asking patients with acute PE about presyncope 
and syncope may inform risk assessment and 
site-of-care decision-making, as these risk factors 
support hospitalization over home discharge.
INTRODUCTION
Patients with acute pulmonary embolism (PE) who present to 
the emergency department (ED) cross a wide severity spectrum: 
low-risk patients may be safe for expedited discharge and 
outpatient management;1,2 intermediate-risk patients may require 
more prolonged cardiopulmonary monitoring and inpatient 
treatment; while high-risk patients may have or develop life-
threatening hemodynamic instability and need aggressive care.3 
Initiating treatments that are tailored to patient needs requires 
reliable risk stratification,4,5 a practice that is endorsed by 
international society guidelines.6,7 
Syncope, a brief, fully reversible transient loss of 
consciousness and postural tone, is a common symptom among 
ED patients with acute PE, found in a large systematic review 
of nearly 22,000 cases to occur in approximately 17% of cases.8 
The true prevalence of syncope in ED patients with acute PE 
is unknown, however, and has varied widely by study, ranging 
from 6.8% to 29.9%.8 That review found that unselected acute 
PE patients with syncope have more severe disease and worse 
prognosis than their non-syncopal counterparts.8 Syncope is 
associated with higher prevalence of hemodynamic instability, 
echocardiographic signs of right ventricular dysfunction, as 
well as a higher risk of 30-day PE-related adverse outcomes and 
in-hospital or 30-day all-cause mortality. What marginal role 
syncope plays in assigning PE patients to escalating risk strata is 
unclear, and only a few prognostic instruments include syncope 
among their prediction variables.5 
Presyncope, also known as near-syncope, is the 
sensation of imminent syncope, but absent a complete loss 
of consciousness. The prevalence of presyncope in patients 
with acute PE is unclear. Whether presyncope carries the 
same implications as syncope in PE patients is unknown, as 
presyncope has been less commonly studied. Few studies of 
acute PE identify presyncope in their population,9,10 and often 
fail to distinguish presyncopal from syncopal patients in their 
analysis.9 The aforementioned systematic review of syncope 
and PE makes no mention of presyncope.8 
Of the 29 studies in the review, only one included 
presyncopal patients. The world’s largest contemporary registry 
of PE, the RIETE (Registro Informatizado de Enfermedad 
TromboEmbólica), includes syncope in its dataset, but not 
presyncope, and the same is true with other registries.11,12 The 
assumption, though, that presyncopal patients should be grouped 
with syncopal patients for analysis is not altogether unjustified. A 
large, 11-center prospective study of all-comers (not restricted to 
PE) with syncope and presyncope in 3581 ED adults ≥60 years of 
age found that presyncope confers similar risks as syncope for the 
composite outcome of death or serious clinical event.13 Whether 
PE patients with presyncope and syncope also have similar 
outcomes has not been established – only 1% of this larger 
syncopal population was diagnosed with acute PE. 
We undertook this secondary analysis of a multicenter, 
community-based cohort of United States ED patients with 
objectively confirmed PE to compare presyncopal with 
syncopal patients in terms of clinical and radiographic 
characteristics. We hypothesize that presyncope is as important 
an historical variable as syncope in the evaluation of ED 
patients with acute PE as both are associated with intensive care 
unit (ICU) admission, our primary outcome. If this hypothesis 
is confirmed, clinicians and researchers evaluating patients 
with acute PE may benefit from including presyncope in their 
calculus of risk assessment and site-of-care decision-making.
METHODS
Study Design and Setting 
We performed a planned secondary analysis of the MAPLE 
(Management of Acute PuLmonary Embolism) dataset.14-16 
MAPLE is a retrospective cohort study conducted from January 
2013–April 2015 in all 21 community medical centers across 
Kaiser Permanente (KP) Northern California, a large integrated 
healthcare system that provides comprehensive medical care 
for more than four million members with approximately 1.2 
million ED visits per year. KP members include at least 33% 
of the population in areas served and are representative of the 
demographic and socioeconomic diversity of the surrounding and 
statewide population.17,18 Characteristics of the 21 medical centers 
at the time of the study are reported elsewhere.14 This study 
was approved by the institutional review board of KP Northern 
California, which granted a waiver of informed consent due to the 
observational nature of the study.
Care for patients with PE was at the discretion of the treating 
physicians. The only structured guidance for PE management 
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occurred during the final eight months of the 28-month MAPLE 
study, during which an electronic clinical decision support tool 
was implemented at select sites to aid emergency physicians 
with site-of-care decision-making: home vs hospital. It did 
not address indications for ICU admission. The tool included 
presyncope and syncope in a list of relative contraindications to 
home management. Details of the eSPEED (electronic Support 
for Pulmonary Embolism Emergency Disposition) controlled 
pragmatic trial are reported elsewhere.1 
Indications for ICU admission of PE patients in our EDs 
are not protocolized. The primary reasons for ICU admission 
of PE patients are current or anticipated hemodynamic 
instability or respiratory insufficiency. PE patients are 
admitted to the ICU also for close monitoring after receiving 
catheter-directed thrombolytics.
Selection of Participants, Data Collection and Processing
We included a consecutive series of adult ED patients ≥18 
years of age with acute, objectively confirmed PE diagnosed 
in the ED or in the preceding 12 hours, as we have described 
previously.14,15 We depict the cohort assembly in Figure 1.
We combined electronic health record (EHR) extraction 
with manual chart abstraction. Thirteen practicing emergency 
physicians abstracted variables from the EHRs after receiving 
standardized training on data collection methods and use of the 
electronic data collection instrument, which was modified to 
its final form after pilot testing.14 A second reviewer abstracted 
specified variables on a randomly selected subset of 90 cases 
from the larger MAPLE study of 2996 patients to measure 
inter-rater reliability, the results of which have been reported 
elsewhere.15 Any case of syncope or presyncope was confirmed 
by a second abstractor blinded to the initial review, and arbitrated 
by a third abstractor if necessary.
We defined syncope as an abrupt, transient, and complete 
loss of consciousness with loss of postural tone, followed by 
rapid, spontaneous recovery. We defined presyncope as the 
sensation of imminent syncope, that is, an abrupt, transient 
feeling of nearly fainting or losing consciousness, followed by 
Figure 1. Cohort assembly of emergency department patients with acute pulmonary embolism.
ED, emergency department; MAPLE, Management of Acute PuLmonary Embolism study; PE, pulmonary embolism; VTE, venous 
thromboembolism.
Screen Electronically 
N = 3,813 cases
Manual Review of Electronic Health Record 
N = 3,213 cases
MAPLE Cohort with 
Complete Outcome Data
N = 2,996 cases
Adults ≥18 years from Jan 2013 to April 2015 
with an ED or inpatient discharge diagnosis 
of non-gravid PE with a VTE imaging study in 
the ED or the 12 hours prior who did not meet 
similar criteria in the preceding 30 days
Exclude cases lacking an ED PE diagnosis 
whose inpatient PE diagnosis was neither 
primary nor present on admission
These ED adults treated for acute objectively-
confirmed PE constitute our MAPLE cohort
• Neither documented presyncope nor 
syncope: n=2,805 (93.6%)
• Presyncope: n=82 (2.7%)
• Syncope: n=109 (3.6%)
Manually Exclude from Complete 
Chart Review 
N = 600 cases
PE not objectively confirmed in the ED (n =379)
PE objectively confirmed in the ED but: (n=221)
• Recent VTE <30 days or non-acute PE (n=101)
• Designated comfort care status in ED (n=60)
• Transferred from the ED to another facility or     
left the ED against medical advice (n=38)
• Insignificant PE, not treated (n=13)
• Age <18 years (n=5)
• Pregnancy known in ED (n=4)
Exclude from Analysis for 
Incomplete Outcome Data
N = 217 cases
Lacking sustained health plan membership for 
at least 30 days following index ED visit
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rapid, spontaneous recovery as documented by the emergency 
physician or consultant physician. Non-specific dizziness and 
light-headedness were not sufficient to constitute presyncope. 
We provided hypothetical patient quotes to our abstractors 
to illustrate the study definition of presyncope: “I almost 
fainted”; “I had to lay down because I felt like I was going 
to pass out”; “My vision darkened, I got hot and sweaty and 
nearly lost consciousness.” 
We have previously described our calculation of the PE 
Severity Index (PESI).19 Proximal clots involved lobar or main 
pulmonary arteries.14 We classified ED patients as having 
massive PE who had systolic blood pressure <90 millimeters 
of mercury sustained over 15 minutes or more, received 
vasopressors or required cardiopulmonary resuscitation, not 
caused by new-onset arrhythmia, hypovolemia, or septic 
shock.6,7,20 We classified ED patients as having submassive PE 
who did not meet massive PE criteria yet had an elevated ED 
troponin level (above the 99th percentile), an elevated B-type 
natriuretic peptide (>100 picograms per milliliter), or right 
ventricular dysfunction on echocardiogram. Findings of right 
ventricular enlargement on computed tomography pulmonary 
angiography (CTPA) were infrequently reported.21 Nearly all 
of the patients with abnormal right ventricular findings on 
CTPA were also positive for right ventricular strain by the 
criteria listed above. 
The interventions we measured were as follows: ED 
ventilatory support included non-rebreather mask; positive-
pressure ventilation; and mechanical ventilation. Advanced clot 
treatment included systemic thrombolysis, catheter-directed 
thrombolysis, and embolectomy. 
Primary and Secondary Outcomes
Our primary outcome was ICU admission from the 
ED. This included patients who en route from the ED to the 
ICU passed through the interventional radiology suite for 
catheter-directed thrombolysis, an infrequent occurrence 
during the study period. Secondary outcomes included 30-
day major hemorrhage, recurrent venous thromboembolism, 
and all-cause mortality.22-24 Major hemorrhage was defined 
by the International Society on Thrombosis and Haemostasis 
as bleeding at high-risk anatomic locations (intracranial, 
intraspinal, intraocular, retroperitoneal, intra-articular, 
pericardial, or intramuscular with compartment syndrome), 
or overt bleeding with either a reduction of hemoglobin ≥2 
grams per deciliter or a transfusion of two or more units of red 
blood cells.25 Recurrent venous thromboembolism was defined 
as a new or expanded abnormality on imaging. Deaths were 
identified using a health system mortality database that links to 
the Social Security Death Master File and the California State 
Department of Vital Statistics to identify deaths both within and 
outside of the healthcare delivery system. We also identified 
out-of-system medical encounters using a comprehensive 
claims database to improve capture of all healthcare visits 
related to our 30-day outcomes. 
Data Analysis
We present continuous variables as medians with 
interquartile ranges (IQR) and categorical data as frequencies 
and proportions. We compare characteristics between groups 
(presyncope vs syncope vs neither) using chi-square tests for 
categorical variables and t-tests or Wilcoxon rank-sum tests 
for continuous variables. A two-tailed p value of less than 0.05 
is considered significant. Covariates that are differentially 
distributed between the three groups of interest were candidates 
for inclusion in the predictive models. 
We examined adjusted associations of syncope and 
presyncope with ICU admission using multivariable logistic 
regression, adjusting for demographics, PESI class, ventilatory 
support, submassive and massive PE classification with standard 
errors adjusted for clustering by medical center. We also tested 
interaction terms between either presyncope and syncope and 
submassive or massive PE and PESI class. We undertook 
sensitivity analyses by excluding massive PE from the predictors 
in the model since the association of sustained hypotension with 
ICU admission is not in question. We also examined adjusted 
associations of the above covariates of interest with the secondary 
outcome of 30-day, all-cause mortality. Adjusted associations 
are reported as odds ratios (aOR) with 95% confidence intervals 
(CI). All analyses were conducted using SAS statistical software, 
version 9.31 (SAS Institute, Cary, NC) and Stata, version 14.2 
(StataCorp LP, College Station, TX).  
RESULTS
Throughout the 28-month study, we identified 2996 
eligible patient encounters (Figure 1). The median age of the 
entire cohort was 66 years (IQR 54-77), and 1485 (49.5%) 
were men. Overall, 82 (2.7%) had presyncope and 109 (3.6%) 
had syncope documented in the EHR. We report in Table 1 
patient demographic, comorbid, and clinical characteristics 
stratified by the three groups: patients with presyncope; 
syncope; and neither. Table 2 highlights notable between-group 
differences in radiographic risk stratification, and management 
characteristics. The presyncope and syncope patients shared in 
common many characteristics distinct from their counterparts 
with neither documented complaint: they more commonly 
arrived by ambulance, had a proximal clot, and a higher PESI 
class, submassive, and massive PE classification. They more 
commonly required ventilatory support and thrombolytics. They 
were also more commonly hospitalized (Table 2).  Overall, 
175 patients (5.8%) were admitted to the ICU: 170 from the 
ED, five of whom passed through interventional radiology for 
catheter-directed thrombolysis (Table 2). The presyncope and 
syncope subgroups had similar prevalence of ICU admission: 
presyncope 18.3% vs syncope 25.7% (compared with 4.7% 
among those with neither condition). 
We report in Table 3 the results of our univariate and 
multivariate analysis for the primary outcome, ICU admission. 
We found that presyncope and syncope were both independently 
associated with ICU admission, as were lower age, higher 
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Patient characteristics
Neither Presyncope 
nor Syncope 
n = 2805 (93.6%)
Presyncope
n = 82 (2.7%)
Syncope
n = 109 (3.6%)
Demographics n % n % n %
Age median (IQR), years 66 (54-77) 67.5 (56-75) 68 (56-77)
Gender male 1390 49.6 34 41.5 61 56.0
Race/ethnicity
White 2002 71.4 66 80.5 74 67.9
African American 357 12.7 6 7.3 21 19.3
Hispanic or Latino 282 10.1 3 3.7 6 5.5
Asian or Pacific Islanders 127 4.5 2 2.4 8 7.3
Other 37 1.3 5 6.1 0 0.0
Comorbidities 
Obesity (body mass index >30 kg/m2) 1267 45.2 46 56.1 46 42.2
Cancer (history of or active) 807 28.8 28 34.2 32 29.4
Chronic lung disease (includes asthma) 762 27.2 19 23.2 29 26.6
Documented history of prior venous 
thromboembolism
466 16.6 15 18.3 12 11.0
Coronary artery disease 404 14.4 12 14.6 19 17.4
Heart failure (diastolic or systolic) 281 10.0 9 11.0 10 9.2
Cerebrovascular disease 235 8.4 6 7.3 11 10.1
Smoking 167 6.0 7 8.5 4 3.7
Chronic severe renal failure 62 2.2 3 3.7 4 3.7
Charlson Comorbiditiy Index Score
Mean (SD) 1.90 (2.39) 1.91 (2.36) 2.03 (2.51)
Median (IQR) 1 (0-3) 1 (0-3) 1 (0-3)
0 1056 37.7 31 37.8 37 33.9
1 535 19.1 11 13.4 28 25.7
≥2 1154 41.1 36 43.9 42 38.5
No measure (no visits in prior year) 60 2.1 4 4.9 2 1.8
IQR, interquartile range; SD, standard deviation.
Table 1. Demographic and comorbid characteristics of emergency department patients with acute pulmonary embolism stratified by 
documentation of presyncope and syncope (n = 2996).
PESI class, ventilatory support, proximal clot location, and 
submassive and massive classification. The association of both 
presyncope and syncope with ICU admission remained when 
massive PE patients were removed from the analysis and only 
normotensive patients remained (see the supplemental files, Table 
S1). There was no significant interaction between either syncope 
or presyncope and PESI, submassive classification or massive 
classification in predicting ICU admission (data not shown). 
Presyncope was thus associated with ICU admission even 
among normotensive patients and those without markers of right 
ventricular dysfunction. 
Four patients (4.9%) in the presyncope group died of any 
cause within 30 days and 10 (9.2%) in the syncope group (p = 
0.40). In adjusted analysis, higher-risk PESI class (Classes III-V; 
aOR 22.17; 95% CI, 7.91-62.14), ventilatory support (aOR 
3.78; 95% CI 2.77-5.16) and massive PE (aOR 3.69; 95% CI, 
1.42-9.59) were independently associated with 30-day all-cause 
mortality (Table 4). Restricting the analysis to normotensive 
patients did not meaningfully change these findings (see the 
supplemental files, Table S2).
DISCUSSION
In this multicenter, retrospective cohort study of community-
based ED patients with acute PE we found a similar prevalence 
of ICU admission (approximately one in five) among patients 
with syncope and those with presyncope. Both groups had a 
four-fold or higher proportion of ICU admission than their 
counterparts with neither complaint. Presyncope and syncope 
were each associated with ICU admission, independent of patient 
demographics, PESI class, ventilatory support, clot location, and 
submassive and massive classification.  
Our finding that both syncopal and presyncopal PE patients 
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Patient characteristics
Neither Presyncope 
nor Syncope 
n = 2805 (93.6%)
Presyncope
n = 82 (2.7%)
Syncope
n = 109 (3.6%)
P-values 
comparing 
three groups
Arrival by ambulance n % n % n %
No 2264 80.7 48 58.5 40 36.7 <0.0001
Yes 541 19.3 34 41.5 69 63.3
PE Severity Index class
I 503 17.9 10 12.2 14 12.8 0.0254
II 615 21.9 13 15.9 14 12.8
III 547 19.5 19 23.2 22 20.2
IV 492 17.5 19 23.2 20 18.4
V 648 23.1 21 25.6 39 35.8
Ventilatory support* 140 5.0 10 12.2 15 13.8 <0.001
Non-rebreather mask only 79 2.8 9  11.0 11 10.1
Non-invasive or invasive ventilation 61 2.2 1 1.2 4 3.7
Clot location on CTPA†
Proximal 1349 48.1 50 61.0 68 62.4 0.0013
Distal 1195 42.6 21 25.6 33 30.3
Unclear or not measured 261 9.3 11 13.4 8 7.3
Massive classification‡
Neither massive nor submassive 1958 69.8 31 37.8 52 47.7 <0.0001
Submassive 829 29.6 49 59.8 50 45.9
Massive 18 0.6 2 2.4 7 6.4
Hospitalization 2184 77.9 77 93.9 105 96.3 <0.0001
To hospital floor 2052 73.2 62 75.6 77 70.6
To intensive care unit 132 4.7 15 18.3 28 25.7
Thrombolytics (n=28)§ 18 0.6 5 6.1 5 4.6 <0.0001
Intravenous (n=23) 14 4 5
Catheter-directed (n=5) 4 1 0
30-day adverse events
Major hemorrhage 79 2.8 3 3.7 8 7.3 0.0236
Recurrent venous thromboembolism 20 0.7 0 0.0 1 0.9 0.7196
All-cause mortality 115 4.1 4 4.9 10 9.2 0.0364
CTPA, computed tomography pulmonary angiography; ED, emergency department; PE, pulmonary embolism.
*Includes non-rebreather mask, non-invasive ventilation, and endotracheal intubation with mechanical ventilation 
†Proximal emboli were clearly lobar or more proximal, whereas distal emboli were “segmental or lobar” or more distal. Location was not 
measured in patients whose PE was diagnosed with ventilation/perfusion scan.
‡Massive PE required systolic blood pressure <90 mmHg sustained over 15 minutes or more, reception of vasopressors or cardiopulmonary 
resuscitation, not caused by new-onset arrhythmia, hypovolemia, or septic shock. Submassive PE did not meet massive PE criteria, yet had 
an elevated ED troponin level, an elevated B-type natriuretic peptide, or right ventricular dysfunction on echocardiogram.
§Thrombolytics were administered in the ED or upon arrival (<2h) to interventional radiology or the intensive care unit.
Table 2. Clinical characteristics of emergency department patients with acute pulmonary embolism stratified by documentation of presyncope 
and syncope (n = 2996).
are at higher and comparable risk for needing intensive care 
than non-syncopal patients is concordant with one of the few 
PE studies to have identified presyncope in their PE population 
and compared them to their syncopal and non-syncopal patients. 
Among 1716 patients with PE enrolled in the prospective 
Italian Pulmonary Embolism Registry, 239 patients (13.9%) 
reported presyncope and 219 (12.8%) reported syncope.10 Their 
presyncopal patients were similar to the syncopal patients on 
most measures. Both groups had significantly higher 30-day, all-
cause mortality than their non-syncopal counterparts: presyncope 
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(47.2%); syncope (37.4%); neither (6.2%). Direct comparisons 
between the Italian registry and our own, however, are prevented 
because of the disparate populations and settings. Their overall 
30-day, all-cause mortality was 15.9%, whereas ours was 4.4%, 
suggesting significant between-site differences in disease severity 
and management.1 
Our results are also consistent with more general studies 
comparing presyncope with syncope patients across a broad 
spectrum of ED complaints. For example, a prospective, 
observational study in 3581 older adults (≥60 years) with 
presyncope or syncope in 11 EDs identified no between-group 
differences in the composite incidence of 30-day mortality 
or serious clinical events.13 These events included cardiac 
arrhythmias, myocardial infarction, cardiac intervention, new 
diagnosis of structural heart disease, stroke, PE, aortic dissection, 
subarachnoid hemorrhage, cardiopulmonary resuscitation, 
internal hemorrhage or anemia, and recurrent fall or syncope 
resulting in major injury. Only 1% of their cohort was diagnosed 
Univariate models Multivariate model
Patient characteristics Odds ratio 95% CI Adjusted odds ratio 95% CI
Age, per year 0.99 0.98-1.00 0.94 0.93-0.96
Gender
Female reference reference
Male 1.06 0.71-1.56 0.99 0.69-1.41
Race/ethnicity
White reference reference
Non-white 1.19 0.86-1.65 1.04 0.70-1.53
PE Severity Index class
  I reference reference
  II 1.74 0.75-4.05 4.27 1.97-9.26
  III 1.83 0.78-4.25 3.67 1.64-8.22
  IV 2.75 1.29-5.87 7.54 3.32-17.10
  V 5.62 2.40-13.15 13.82 5.98-31.94
(Pre)syncope classification
Neither reference reference 
Presyncope 4.53 2.30-8.95 2.79 1.40-5.56
Syncope 7.00 4.36-11.23 4.44 2.52-7.80
Ventilatory support*
None reference  reference
Any 10.51 7.39-14.94 4.06 2.52-6.53
Clot location on CTPA†
Distal reference reference
Proximal 3.07 2.16-4.37 2.23 1.47-3.38
Unclear or not measured 0.94 0.34-2.58 0.67 0.28-1.58
(Sub)massive classification‡
Neither reference reference
Submassive 5.03 3.74-6.75 3.32 2.26-4.88
Massive 139.37 56.78-342.10 36.49 12.33-107.98
CI, confidence interval; CTPA, computed tomography pulmonary angiography; PE, pulmonary embolism.
*Includes non-rebreather mask, non-invasive ventilation, and endotracheal intubation with mechanical ventilation.
†Proximal emboli were clearly lobar or more proximal, whereas distal emboli were “segmental or lobar” or more distal. Location was not 
measured in patients whose PE was diagnosed with ventilation/perfusion scan.
‡Massive PE required systolic blood pressure <90 mmHg sustained over 15 minutes or more, reception of vasopressors or cardiopulmonary 
resuscitation, not caused by new-onset arrhythmia, hypovolemia, or septic shock. Submassive PE did not meet massive PE criteria, yet had 
an elevated ED troponin level, an elevated B-type natriuretic peptide, or right ventricular dysfunction on echocardiogram.
Table 3. Association between patient characteristics and intensive care unit admission among emergency department patients with acute 
pulmonary embolism (n = 2996).
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with acute PE, however, so these investigators cannot speak 
directly to our particular study population. Nevertheless, their 
findings suggest that presyncopal ED patients carry similar short-
term risks as syncopal ED patients and should be managed in a 
similar fashion. 
Syncope is a known predictor of adverse events in unselected 
ED patients with acute PE, as it correlates with a higher 
prevalence of hemodynamic instability and right ventricular 
dysfunction at the time of PE presentation and confers a higher 
risk for adverse outcomes.8,26 But the correlation between 
syncope and adverse outcomes has disappeared in some studies 
when patients presenting with hypotension were removed from 
the cohort, according to the results of a recent 29-study meta-
Univariate models Multivariate model
Patient characteristics Odds ratio 95% CI Adjusted odds ratio 95% CI
Age, per year 1.03 1.02-1.04 1.01 0.99-1.02
Gender
Female reference reference
Male 0.77 0.52-1.15 0.67 0.44-1.02
Race/ethnicity
White reference reference
Non-white 0.86 0.56-1.32 0.95 0.61-1.47
PE Severity Index class
I-II reference reference
III-V 10.17 2.61-16.81 22.17 7.91-62.14
(Pre)syncope classification
Neither reference reference 
Presyncope 1.20 0.47-3.03 0.77 0.34-1.75
Syncope 2.36 1.03-5.44 1.41 0.45-4.37
Ventilatory support*
None reference  reference
Any 6.78 5.07-9.07 3.78 2.77-5.16
Clot location on CTPA†
Distal reference reference
Proximal 1.12 0.82-1.53 0.97 0.69-1.36
Unclear or not measured 1.72 0.94-3.15 1.54 0.80-2.95
(Sub)massive classification‡
Neither reference reference
Submassive 1.51 1.15-2.00 0.88 0.64-1.23
Massive 16.32 7.46-35.72 3.69 1.42-9.59
CI, confidence interval; CTPA, computed tomography pulmonary angiography; PE, pulmonary embolism.
* Includes non-rebreather mask, non-invasive ventilation, and endotracheal intubation with mechanical ventilation
†Proximal emboli were clearly lobar or more proximal, whereas distal emboli were “segmental or lobar” or more distal. Location was not 
measured in patients whose PE was diagnosed with ventilation/perfusion scan.
‡ Massive PE required systolic blood pressure <90 millimeters mercury sustained over 15 minutes or more, reception of vasopressors or 
cardiopulmonary resuscitation, not caused by new-onset arrhythmia, hypovolemia, or septic shock. Submassive PE did not meet massive PE 
criteria yet had an elevated ED troponin level, an elevated B-type natriuretic peptide, or right ventricular dysfunction on echocardiogram.
Table 4. Associations between patient characteristics and 30-day all-cause mortality among emergency department patients with acute 
pulmonary embolism (n = 2996).
analysis of nearly 22,000 patients with PE.8 The authors suggest 
that hemodynamic instability (rather than syncope itself) may 
be driving the correlation. Presyncope was not included in 
the analysis given its near absence from the included studies. 
However, our study suggests that the increased risk imparted 
by presyncope or syncope is independent of hemodynamic 
instability, since our findings were insensitive to removal of 
patients with massive PE from the analysis. These results suggest 
that the effect of presyncope and syncope on PE outcomes is not 
mediated exclusively by hemodynamic instability and carries an 
independent prognostic role, even in normotensive patients and 
even when adjusted for other variables known to confer risk of 
adverse outcomes, such as right ventricular dysfunction. 
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Pulmonary emboli are thought to cause presyncope and 
syncope by mechanical, neurohumoral, and tachydysrhythmic 
mechanisms. Large, central PE can work at the mechanical 
level, creating direct right ventricle outflow obstruction, which 
can lead to a downstream reduction in left ventricular filling 
and cardiac output. Proximal clots are more prevalent among 
PE patients with presyncope or syncope than those without: 
we found this in our study (61.7% vs 48.1% [p = 0.001; 
Table 2]), as have others.27-29 Nevertheless, about 40% of our 
presyncope/syncope cohort did not have proximal clots at the 
time of CTPA. PE, however, is a dynamic condition and some 
of these patients may have had larger, more central clots earlier 
that had subsequently undergone partial in vivo fibrinolysis 
and fragmentation by the time of imaging.29 The increase in 
pulmonary hypertension can manifest with right ventricular 
dysfunction (and qualify patients for submassive classification). 
Right ventricular dysfunction was more prevalent in our 
presyncope/syncope patients compared with their non-syncopal 
counterparts: 51.8 % vs 29.6% (p<0.0001; Table 2), results that 
are also consistent with other studies.8,9,28 
Smaller and more distal clots lack the mechanical effects 
of their larger, proximal counterparts, but can still impede 
cardiac function through biochemically-induced pulmonary 
vasoconstriction. PE may also cause presyncope and syncope 
by provoking paroxysmal tachydysrhythmias, as well as 
by transiently increasing vagal tone.29,30 These various 
mechanisms of presyncope and syncope do not each carry 
the same implications. A transient vagal reaction in a patient 
with acute PE generally has less prognostic significance than a 
large, central clot with evidence of persistent right ventricular 
dysfunction. Given, however, that presyncope and syncope 
are independently associated with ICU admission, even after 
controlling for known prognostic factors, including clot location 
and right ventricular dysfunction, we think it wise to initially 
hospitalize this population of PE patients for monitoring.      
We have already incorporated these results into our ED 
PE clinical pathway by denoting presyncope an indication 
for hospitalization. In an electronic clinical decision support 
application to assist emergency physicians in real-time, site-
of-care decision-making, we provide two complementary 
risk-stratification tools. The first is the PESI, accurately auto-
populated from the EHR.1,19,31 The second tool is a memory-
jogging list of relative contraindications to immediate 
outpatient care. Among the PE-related factors, we include 
presyncope alongside syncope.1 The results of this current 
study, while only suggestive, nevertheless lend weight 
to considering presyncope a relative contraindication to 
immediate home discharge among ED patients with acute PE. 
Likewise, for patients diagnosed with PE in the primary care 
setting, presyncope and syncope may both be an indication for 
transfer to a higher level of care.32 
LIMITATIONS
The major shortcoming of this study is its retrospective 
design, which likely underestimates the prevalence of 
presyncope and syncope. We were able to manually abstract 
presyncope and syncope from the EHR in a structured fashion 
and achieved the agreement of two physician abstractors. 
But not all presyncopal and syncopal events made it to the 
health record, as patient reporting, physician inquiry, and 
physician documentation were all subject to incompleteness. 
Physicians may have been more inclined to inquire and to 
document presyncope and syncope in patients with more 
severe manifestations of PE, but how this potential bias, if it 
exists, may have affected our results is unclear. Nevertheless, 
this limitation in design attenuates the claims we can make 
from our results. 
Moreover, our primary outcome, ICU admission, was not 
protocolized, and may have been influenced by many patient-, 
physician-, and facility-level variables. When attempting 
to isolate the effect of presyncope and syncope upon ICU 
admission, we adjusted for multiple high-risk factors, but 
could not account for excluded and unmeasured variables. 
Additionally, the results we found reflect the study population 
and setting and may not be generalizable to other geographic 
locations, practice settings and case mixes. As expected, the 
number of patients in the presyncope and syncope subgroups 
who died was small. Although we found no significant adjusted 
association between presyncope or syncope and mortality, the 
low observed incidence and relatively small study cohort limit 
any conclusions about mortality effects.
While ICU admission as an outcome variable can be 
construed as too variable (eg, interfacility differences in 
admission criteria) and too subjective (based on physician 
judgment), these factors were minimized by the large number 
of centers (n = 21) and physicians involved. As such, ICU 
admission represents a valid proxy for tenuous clinical status. 
The increase in ICU admission among the presyncope/syncope 
population was not exclusively attributable to hemodynamic 
status (eg, massive classification), need for ventilatory support, 
clot location, right ventricular dysfunction, or predicted short-
term mortality (PESI classification). 
CONCLUSION
Little attention has been paid to the prognostic significance 
of presyncope in ambulatory adults with acute PE. This 
retrospective study suggests that presyncope carries similar risks 
as syncope in the PE population, an hypothesis supported by the 
Italian PE registry as well as the broader presyncope literature.10,13 
Prospective studies are needed to quantify the magnitude of 
the association between presyncope and high-risk clinical 
characteristics and short-term adverse outcomes, as well as to 
tease out more clearly the prognostic import of presyncope in 
the normotensive population and those without right ventricular 
dysfunction. Meanwhile, it may be sensible to add presyncope 
to the list of questions we ask of our PE patients when making 
site-of-care decisions and to consider it a prognostic factor 
comparable to syncope. 
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